VERFAHREN

Patent europeic · EP3171891 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3171891
Numer da la dumonda
EP15756845
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
10-07-2015
Publitgà
31-05-2017
Concedì
10-09-2025
La protecziun finescha il pli tard
09-07-2035
Proxima taxa annuala scadenta
31-07-2027
Classas IPC
A61K 39/395 (2006.01)
C12N 9/24 (2006.01)
Prioritad
GB 201413240 25.07.2014
Dumonda PCT
PCT/EP2015/065895 10.07.2015
Publicaziun PCT
WO2016/012285 28.01.2016
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-08-2026

    Next annual fee due on

    Next annual fee due on
    31.07.2026 → 31.07.2027

    Published in Swissreg on 01.08.2026

  2. 22-07-2026

    Midada

    Published in Swissreg on 22.07.2026

  3. 18-11-2025

    Represchentant inscrit

    Representative
    Isler & Pedrazzini AG, Postfach, 8027 Zürich

    Published in Swissreg on 18.11.2025

  4. 10-09-2025

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 10.09.2025

Partidas

Possessur

Hansa Biopharma AB

Box 785, 220 07 Lund, SE

Represchentant

Isler & Pedrazzini AG

Postfach, 8027 Zürich

Inventur

KJELLMAN, Christian

SE 220 07 Lund, SE

JARNUM, Sofia

SE 220 07 Lund, SE

WINSTEDT, Lena

SE 220 07 Lund, SE

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.